These findings indicate that METTL1 promotes MDSC accumulation and an immunosuppressive microenvironment by regulating TGF-β2 translation, thereby impairing CD8+ T cell-mediated anti-tumor immunity—a key mechanism underlying HCC recurrence and immune evasion (9). This evidence concerns the gene METTL1 and hepatocellular carcinoma.